Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation.

Int J Chron Obstruct Pulmon Dis · 2022 · PMC8906822 · PMID 35281476

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Kaplan–Meier rates of all-cause and COPD-related readmissions were numerically lower in the prompt compared with the delayed cohort but did not reach statistical significance ( Figure 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.